TYMS and DPYD polymorphisms in a Turkish population
- 180 Downloads
The thymidylate synthase (TS) and dihydropyrimidine dehydrogenase (DPD) enzymes affect the outcome of 5-fluorouracil (5-FU)-based chemotherapy. Genetic polymorphisms of the thymidylate synthase (TYMS) and dihydropyrimidine dehydrogenase (DPYD) genes that may affect chemotherapy are described. The aim of this study was to determine the frequencies of TYMS and DPYD polymorphisms in healthy Turkish individuals.
Genotyping analyses of the promoter enhancer region of TYMS (TSER) and the exon 14-skipping mutation of the DPYD (DPYD*2A) genes were conducted in 250 unrelated, healthy volunteers from the central region of Turkey using a PCR-based assay.
The distribution of theTSER*2/*2, *2/*3 and *3/*3 genotypes were 17.6%, 48.8%, and 33.6%, respectively. The frequencies of the TSER*2 and *3 alleles in the Turkish population were 0.42 and 0.58, respectively. No individuals with the variant DPYD*2A allele were identified in the study group.
The frequency of the TSER*3 allele among members of the Turkish population was similar to frequencies observed in other Caucasian populations but was lower than those found in Japanese and Chinese populations.
KeywordsTYMS DPYD Polymorphism Turkish
This work was supported by a grant from the Ankara University, Institute of Biotechnology, Project No: 2001-K-120-240.
- 12.Raida M, Schwabe W, Hausler P, van Kuilenburg ABP, van Gennip AH, Behnke D, Hoffken D (2001) Prevalence of common point mutation in the dihydropyrimidine dehydrogenase (DPD) gene within the 5′-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)-related toxicity compared with contols. Clin Cancer Res 7: 2832–2839PubMedGoogle Scholar
- 17.Morrison GB, Bastianm A, Dela-Rosa T, Diasio RB, Takimoto CH (1997) Dihydropyrimidine dehydrogenase deficiency: a pharmacogenetic defect causing severe advers reactions to 5-fluorouracil based chemotherapy. Oncol Nursing Forum 24:83–88Google Scholar
- 18.van Kuilenburg ABP, Muller EW, Haasjes J, Meinsma R, Zoetekouw L, Waterham HR, Baas F, Richel DJ, van Gennip AH (2001) Lethal outcome of a patient with a complete dihydropyrimidine dehydrogenase (DPD) deficiency after administration of 5-fluorouracil: frequency of the common IVS14+1G>A mutation causing DPD deficiency. Clin Cancer Res 7:1149–1153PubMedGoogle Scholar
- 36.Yamaguchi K, Arai Y, Kanda Y, Akagi K (2001) Germline mutation of dihydropyrimidine dehydrogenase gene among a Japanese population in relation to toxicity to 5-fluorouracil. Jpn J Can Res 92:337–342Google Scholar
- 37.Hamdy SI, Hiratsuka M, Narahara K, El-Enany M, Moursi N, Ahmed MSE, Mizugaki M (2002) Allele and genotype frequencies of polymorphic cytochromes P450 (CYP2C9, CYP2C19, CYP2E1) and dihydropyrimidine dehydrogenase (DPYD) in the Egyptian population. Br J Clin Pharmacol 53:596–603CrossRefPubMedGoogle Scholar